MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$9K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from loan payable with ...
Accrued liabilities
Accounts payable
Others
Negative Cash Flow Breakdown
Net loss for the period
Other assets
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Accounts payable
-
1,653
-
-
Accounts payable, related party
-
0
-
0
Loss on disposal of property and equipment
-
0
0
0
Amortization of right-of-use assets
-
-
100
194
Operating lease payments
-
-
116
229
Net loss for the period
-7,634
-7,759
-5,123
-12,586
Stock-based compensation
129
42
44
391
Change in fair value of warrants
-
0
-
-
Depreciation of property and equipment
2
4
11
7
Noncash operating lease expense
104
396
-
-
Interest on lease liabilities
3
5
8
21
Interest on loan payable to related party
433
347
220
276
Unrealized gain on short-term investment
0
-
-
-
Prepaid expenses
-364
196
156
-396
Other assets
1,172
1,122
366
1,470
Related party payable
-
-
0
-
Change in operating lease liability
-116
-462
-
-
Accounts payable
701
-
-1,423
1,621
Accrued liabilities
1,147
1,398
-610
2,641
Cash used in operating activities
-5,841
-5,841
-7,411
-8,738
Proceeds from disposal of property and equipment
-
0
0
0
Purchase of property and equipment
-
0
-
-
Cash provided by investing activities
0
0
0
0
Repayment of loan with related party
-
0
0
100
Issuance of common shares and warrants-November Two Thousand And Twenty Four Public Offering
-
0
-
-
Proceeds from issuance of common stock-Committed Equity Facility
-
-
0
0
Issuance of common shares-June2024Registered Direct Offering
-
0
-
-
Issuance of common shares and warrants-Registered Direct Offering
-
-
0
0
Proceeds from warrant exercise-June Two Thousand And Twenty Four Pre Funded Warrant
-
0
-
-
Issuance of common shares and warrants-January Two Thousand And Twenty Four Public Offering
-
0
0
0
Issuance of common shares and warrants-Hanmi Private Placement
-
0
0
0
Issuance of common shares-Two Thousand Twenty Three Committed Equity Facility
-
0
-
-
Issuance of common shares-The2022Atm Offering
-
0
0
0
Proceeds from loan payable with related party
5,850
8,300
7,750
2,600
Issuance of common shares-The2025ATMOffering
0
0
0
828
Issuance of common shares-Employee Stock Purchase Plan
0
0
0
1
Cash provided by financing activities
5,850
8,300
7,750
3,329
Effect of exchange rate fluctuations on cash
0
-
-
-
Increase (decrease) in cash and restricted cash
9
2,459
339
-5,409
Cash and restricted cash, beginning of period
4,096
1,637
6,707
-
Cash and restricted cash, end of period
4,105
4,096
1,637
-
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from loan
payable with related...
$5,850K
Cash provided by
financing activities
$5,850K
Increase (decrease) in
cash and restricted...
$9K
Canceled cashflow
$5,841K
Accrued liabilities
$1,147K
Accounts payable
$701K
Interest on loan payable
to related party
$433K
Prepaid expenses
-$364K
Stock-based compensation
$129K
Noncash operating lease
expense
$104K
Interest on lease
liabilities
$3K
Depreciation of property and
equipment
$2K
Cash used in
operating activities
-$5,841K
Canceled cashflow
$2,883K
Net loss for the
period
-$7,634K
Other assets
$1,172K
Buy us a coffee
Aptose Biosciences Inc. (APTOF)
Aptose Biosciences Inc. (APTOF)